NDAVAGINALINSERT, EXTENDED RELEASE
Approved
Mar 2003
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
5/8 — Partial
FEMRING (estradiol acetate) by Millicent Pharma is characteristics. Approved for moderate to severe vasomotor symptoms due to menopause (), moderate to severe vulvar, vaginal atrophy due to menopause () 1. First approved in 2003.
Drug data last refreshed 10h ago · AI intelligence enriched 13h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FEMRING is an extended-release vaginal insert containing estradiol acetate, a potent estrogen receptor agonist approved for moderate to severe vasomotor symptoms and vulvovaginal atrophy associated with menopause. The drug works by binding to nuclear estrogen receptors in target tissues and suppressing elevated gonadotropin levels in postmenopausal women. Estradiol is the principal intracellular human estrogen and substantially more potent than its metabolites.
$7.0MPart D
LOE ApproachingProduct is approaching loss of exclusivity with modest Part D spending ($7M), suggesting a smaller, defensive brand team focused on retention and lifecycle management.
Mechanism of Action
characteristics. Although circulating estrogens exist in a dynamic equilibrium of metabolic interconversions, estradiol is the principal intracellular human estrogen and is substantially more potent than its metabolites, estrone and estriol, at the receptor level. The primary source of estrogen in…
Indications (3)
Worked on FEMRING at Millicent Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.